A contract between a health plan issuer and a 340B covered entity may not pay less for a drug than the national average drug acquisition cost, pay a lower dispensing fee, or carry a fee that other providers do not pay. An issuer may not interfere with an enrollee's choice of a 340B covered entity or its contract pharmacies. A second section sets like rules for Medicaid managed care organizations and 340B grantees.
Bill
SB 263
Act
Senate Bill 263, 133rd General Assembly
Session
2020
In effect
12 April 2021
Applies to
Health plan issuers and their third-party administrators; Medicaid managed care organizations
Limits
The Medicaid managed care section is shown as amended by House Bill 96 in 2025.
Enforcement
A contract term that breaks the rule is unenforceable and gives way to the rate paid to other providers.
No health plan issuer or third-party administrator making payments pursuant to a health benefit plan shall discriminate against a 340B covered entity in a manner that prevents or interferes with an enrollee's choice to receive a prescription drug from a 340B covered entity or its contracted pharmacies
Each 340B covered entity sends the Ohio Department of Health a yearly report: what it paid for 340B drugs, what it was paid for them by payer type, what it paid contract pharmacies and others, how many contract pharmacies it uses, and an accounting of what it spent from 340B proceeds. The department posts the reports on its website.
Bill
HB 96
Act
House Bill 96, 136th General Assembly
Session
2025
In effect
30 September 2025
Applies to
340B covered entities; the Ohio Department of Health
Limits
The first report is due by July 1, 2026, and one is due each July 1 after that.
Not later than July 1, 2026, and not later than the first day of July in each year thereafter, each 340B covered entity shall submit a report to the department of health
Plain-language summaries, not legal advice. Laws change, and court rulings on them are not covered here. Read the state’s own page before you rely on one.